Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN DIEGO, CA--(Marketwired - Apr 21, 2015) - Invivoscribe Technologies, Inc. (IVS) announced today the commercial release of four CE-marked LymphoTrack® Dx next-generation sequencing (NGS)...
-
SAN DIEGO, CA--(Marketwired - Mar 17, 2015) - A Genection(TM), Inc., uma subsidiária da Invivoscribe Technologies(R), Inc., anunciou hoje o lançamento do MyAML(TM), um ensaio de...
-
SAN DIEGO, CA--(Marketwired - Mar 17, 2015) - Genection(TM), Inc., una subsidiaria de Invivoscribe Technologies(R), Inc., anunció hoy que ha lanzado MyAML(TM), un ensayo de secuenciación...
-
SAN DIEGO, CA--(Marketwired - Mar 17, 2015) - Genection™, Inc., a subsidiary of Invivoscribe Technologies®, Inc., announced today that it has launched MyAML™, a CLIA validated next...
-
SAN DIEGO, CA--(Marketwired - Jul 18, 2013) - Invivoscribe Technologies, Inc. ("Invivoscribe") hat erfolgreich seine Verfahrensansprüche, die den Kern des Europäischen Patents, welches...
-
SAN DIEGO, CA--(Marketwired - Jul 16, 2013) - Invivoscribe Technologies, Inc. ("Invivoscribe") ha defendido con éxito las reclamaciones de métodos en la base de las patentes...
-
SAN DIEGO, CA--(Marketwired - Jul 16, 2013) - Invivoscribe Technologies, Inc. ("Invivoscribe") defendeu com sucesso as reivindicações do método da parte central das patentes...
-
SAN DIEGO, CA--(Marketwired - Jul 16, 2013) - Invivoscribe Technologies, Inc. ("Invivoscribe") has successfully defended the method claims at the core of international patents covering FLT3...
-
SAN DIEGO, CA--(Marketwired - Jun 19, 2013) - En el asunto de Association of Molecular Pathology c. Myriad, la Corte Suprema de los Estados Unidos rechazó las reclamaciones de patentes de...
-
SAN DIEGO, CA--(Marketwired - Jun 19, 2013) - In Association of Molecular Pathology v. Myriad, the U.S. Supreme Court struck down BRCA1 and BRCA2 gene patent claims. It is important for the...